|
Atomistry » Iodine » PDB 3kxn-3otd » 3orn | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Atomistry » Iodine » PDB 3kxn-3otd » 3orn » |
Iodine in PDB 3orn: Mitogen-Activated Protein Kinase Kinase 1 (MEK1) in Complex with CH4987655 and Mgamp-PnpEnzymatic activity of Mitogen-Activated Protein Kinase Kinase 1 (MEK1) in Complex with CH4987655 and Mgamp-Pnp
All present enzymatic activity of Mitogen-Activated Protein Kinase Kinase 1 (MEK1) in Complex with CH4987655 and Mgamp-Pnp:
2.7.12.2; Protein crystallography data
The structure of Mitogen-Activated Protein Kinase Kinase 1 (MEK1) in Complex with CH4987655 and Mgamp-Pnp, PDB code: 3orn
was solved by
C.M.Lukacs,
C.Janson,
V.Schuck,
C.Belunis,
with X-Ray Crystallography technique. A brief refinement statistics is given in the table below:
Other elements in 3orn:
The structure of Mitogen-Activated Protein Kinase Kinase 1 (MEK1) in Complex with CH4987655 and Mgamp-Pnp also contains other interesting chemical elements:
Iodine Binding Sites:
The binding sites of Iodine atom in the Mitogen-Activated Protein Kinase Kinase 1 (MEK1) in Complex with CH4987655 and Mgamp-Pnp
(pdb code 3orn). This binding sites where shown within
5.0 Angstroms radius around Iodine atom.
In total only one binding site of Iodine was determined in the Mitogen-Activated Protein Kinase Kinase 1 (MEK1) in Complex with CH4987655 and Mgamp-Pnp, PDB code: 3orn: Iodine binding site 1 out of 1 in 3ornGo back to Iodine Binding Sites List in 3orn
Iodine binding site 1 out
of 1 in the Mitogen-Activated Protein Kinase Kinase 1 (MEK1) in Complex with CH4987655 and Mgamp-Pnp
Mono view Stereo pair view
Reference:
Y.Isshiki,
Y.Kohchi,
H.Iikura,
Y.Matsubara,
K.Asoh,
T.Murata,
M.Kohchi,
E.Mizuguchi,
S.Tsujii,
K.Hattori,
T.Miura,
Y.Yoshimura,
S.Aida,
M.Miwa,
R.Saitoh,
N.Murao,
H.Okabe,
C.Belunis,
C.Janson,
C.Lukacs,
V.Schuck,
N.Shimma.
Design and Synthesis of Novel Allosteric Mek Inhibitor CH4987655 As An Orally Available Anticancer Agent. Bioorg.Med.Chem.Lett. V. 21 1795 2011.
Page generated: Sun Aug 11 15:59:33 2024
ISSN: ISSN 0960-894X PubMed: 21316218 DOI: 10.1016/J.BMCL.2011.01.062 |
Last articlesZn in 9JPJZn in 9JP7 Zn in 9JPK Zn in 9JPL Zn in 9GN6 Zn in 9GN7 Zn in 9GKU Zn in 9GKW Zn in 9GKX Zn in 9GL0 |
© Copyright 2008-2020 by atomistry.com | ||
Home | Site Map | Copyright | Contact us | Privacy |